MARKET

ORGO

ORGO

Organogenesis Hldgs Inc
NASDAQ
2.510
+0.160
+6.81%
After Hours: 2.510 0 0.00% 16:01 05/01 EDT
OPEN
2.380
PREV CLOSE
2.350
HIGH
2.570
LOW
2.355
VOLUME
462.79K
TURNOVER
0
52 WEEK HIGH
4.705
52 WEEK LOW
1.795
MARKET CAP
332.76M
P/E (TTM)
67.29
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ORGO last week (0422-0426)?
Weekly Report · 2d ago
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. Fell 6.6% to $339.37 on Thursday. Caterpillar reported better-than-expected first-quarter EPS but missed revenue estimates. Barfresh Food Group, Inc. Shares surged 87.2% after the company reported better than expected results. Chicken Soup for the Entertainment for the Soul Entertainment dropped 75%.
Benzinga · 6d ago
CETX, ATNI and MNY among mid-day movers
On the Move CETX, ATNI and MNY among mid-day movers. Loar Holdings and Safe & Green Holdings Corp are among the Gainers. E-Home Household Service Holdings Ltd. Is one of the losers in the SA market.
Seeking Alpha · 6d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Aclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday's regular session. Akso Health Group ( NASDAQ:AHG) shares increased by 29.87%. Processa Pharma (NASdaq:PCSA) stock increased by 43.18%. Cyclacel Pharmaceuticals stock declined by 33.1% during the session.
Benzinga · 6d ago
Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers
Healthcare On the Move: Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers. S&P 500 Health Care Sector -0.23% to 1637.36. Pharmaceuticals and Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 6d ago
Weekly Report: what happened at ORGO last week (0415-0419)?
Weekly Report · 04/22 09:34
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
First quarter of fiscal year 2024 financial results will be reported after the market closes on Thursday, May 9th. Organogenesis Holdings Inc. Is a leading regenerative medicine company focused on the Advanced Wound Care and Surgical & Sports Medicine markets. The company's shares are listed on the Nasdaq.
Barchart · 04/16 06:30
Weekly Report: what happened at ORGO last week (0408-0412)?
Weekly Report · 04/15 09:31
More
About ORGO
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.

Webull offers Organogenesis Holdings Inc stock information, including NASDAQ: ORGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORGO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORGO stock methods without spending real money on the virtual paper trading platform.